Minerva Neurosciences (NERV) Selling, General & Administrative (2013 - 2026)
Minerva Neurosciences (NERV) reported Selling, General & Administrative of $3.45 million for Q2 2026, up 66.4% from $2.08 million a year earlier but down 69.7% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Minerva Neurosciences' Selling, General & Administrative came in at $19.6 million, up 103.4% year-over-year; for FY2025, it was $9.34 million, down 6.1% from FY2024.
- Selling, General & Administrative has declined for six consecutive years, with a five-year compound annual growth rate of -11.6% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $9.95 million in FY2024 (-4.5%), $10.41 million in FY2023 (-1.6%), $10.58 million in FY2022 (-20.6%) and $13.33 million in FY2021 (-22.9%).
- Five-year quarterly Selling, General & Administrative spans a low of $1.88 million in Q4 2022 and a high of $11.42 million in Q1 2026.
- Year over year, Selling, General & Administrative has now increased in each of the last three quarters, with growth averaging 48.5% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q1 2026 (growth of 349.4%); the low point was Q4 2021 (a decline of 29.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.42 million (Q1 2026), $2.81 million (Q4 2025) and $1.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Minerva Neurosciences | 154.91 Mn | 154.91 Mn | - | 3.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.45 Mn |
| Mar 31, 2026 | 11.42 Mn |
| Dec 31, 2025 | 2.81 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | 2.48 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 2.64 Mn |
| Jun 30, 2023 | 2.63 Mn |
| Mar 31, 2023 | 2.69 Mn |
| Dec 31, 2022 | 1.88 Mn |
| Sep 30, 2022 | 2.84 Mn |
| Jun 30, 2022 | 2.83 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Sep 30, 2021 | 3.00 Mn |
API Access
Minerva Neurosciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();